NewAmsterdam Pharma Company N.V. - Warrant — Cash Flow (NASDAQ:NAMSW)

Financials

Cash from operating activities —141.22 M158.56 M147.78 M 147.78 M Cash from investing activities —24 K62.85 M174.92 M 174.92 M Cash from financing activities —8.91 M659.51 M29.52 M 29.52 M Free cash flow —141.19 M157.89 M147.54 M 147.54 M

NAMSW

Financials

ニュース

NewAmsterdam: Obicetrapib MAA Filings Merit Continued 'Buy' Rating (NASDAQ:NAMS)

abrdn Life Sciences Investors Q1 2025 Commentary

abrdn World Healthcare Fund Q4 2024 Commentary (NYSE:THW)